Pine Haven Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$731K Buy
1,388
+63
+5% +$35.3K 0.49% 57
2026
Q1
$745K Buy
1,325
+17
+1% +$10.9K 0.55% 50
2025
Q4
$885K Buy
1,308
+44
+3% +$30K 0.63% 46
2025
Q3
$808K Buy
1,264
+59
+5% +$35.8K 0.58% 49
2025
Q2
$646K Buy
1,205
+50
+4% +$23.9K 0.51% 55
2025
Q1
$485K Buy
1,155
+80
+7% +$34.7K 0.41% 58
2024
Q4
$444K Buy
1,075
+102
+10% +$44.7K 0.37% 62
2024
Q3
$492K Buy
973
+119
+14% +$57.8K 0.4% 61
2024
Q2
$416K Buy
854
+62
+8% +$31.1K 0.36% 70
2024
Q1
$428K Buy
792
+30
+4% +$16.4K 0.38% 68
2023
Q4
$423K Hold
762
0.4% 65
2023
Q3
$333K Buy
762
+37
+5% +$18.5K 0.35% 70
2023
Q2
$364K Sell
725
-57
-7% -$27.3K 0.36% 69
2023
Q1
$391K Buy
782
+24
+3% +$11.5K 0.41% 65
2022
Q4
$309K Buy
758
+23
+3% +$8.93K 0.34% 73
2022
Q3
$239K Buy
735
+30
+4% +$11K 0.29% 85
2022
Q2
$247K Buy
705
+120
+21% +$48.9K 0.29% 88
2022
Q1
$320K Buy
585
+75
+15% +$39.5K 0.31% 77
2021
Q4
$336K Buy
+510
New +$320K 0.31% 78

Other funds holding IDXX

Pine Haven Investment Counsel's IDXX Position: Q2 2026 in Review

Pine Haven Investment Counsel increased its Idexx Laboratories (IDXX) stake by 4.8% in Q2 2026, buying an estimated $35.3K and bringing the position to 1,388 shares worth $731K. The position accounts for 0.49% of the portfolio, ranked #57.

Pine Haven Investment Counsel first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $885K in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Pine Haven Investment Counsel held 1,388 shares of Idexx Laboratories worth $731K as of Q2 2026.
  • Pine Haven Investment Counsel bought 63 Idexx Laboratories shares in Q2 2026, an estimated $35.3K.
  • Idexx Laboratories made up 0.49% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #57 holding.
  • Pine Haven Investment Counsel first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Pine Haven Investment Counsel's Idexx Laboratories position peaked at $885K in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.